Local heat therapy for persistent high-risk HPV infection
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether local heat therapy can help clear a high-risk HPV infection that has lasted at least 3 months. It is for women who have no serious cervical cell changes or only mild changes (CIN) and who are generally healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have a high-risk HPV infection that has lasted at least 3 months.
- Your cervical biopsy shows no cell changes or only mild changes (CIN).
- You have a regular sex life and are generally healthy.
- You are not pregnant and haven't had any local or systemic treatment in the last 3 months.
- You do not have other serious gynecological infections, inflammation, or tumors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether heat therapy (hyperthermia) can help treat viral warts in people who are pregnant, have HIV/AIDS, autoimmune diseases, diabetes, take immune-suppressing drugs, or are children. It aims to find a safe and effective option for these groups.
This study tests two different ways to treat early cervical changes caused by HPV in women living with HIV. It compares using one heating probe versus two heating probes to destroy abnormal cervical tissue, and measures which approach works better and is easier to use.
This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.
This study compares two treatments—photodynamic therapy using a special light-activated cream and a CO2 laser—to see which works better for clearing low-grade cervical changes caused by a long-lasting high-risk HPV infection. The goal is to find a safe, effective option for women who have had this condition for over a year.
This Phase 2 study tests whether a curcumin (a natural plant compound) cream/gel applied to the cervix can help treat cervical cell changes linked to HPV. It focuses on people with mild (LSIL) or recently treated severe (HSIL) precancer changes, aiming to reduce disease and improve healing.
This study tests two different approaches to treating early cervical changes in women living with HIV who tested positive for HPV (a virus that can cause cervical cancer). The goal is to see which approach works better and is easier to use in South Africa.
Hear when a new Cervical Intraepithelial Neoplasia (CIN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.